Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $31.7800 (-2.66%) ($31.5800 - $32.5900) on Tue. May. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 22 | Latest Price | $31.7800(-2.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -5.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(41%) IWO(38%) XBI(36%) IWM(35%) IBB(34%) | Factors Impacting HALO price | HALO will decline at least -1.375% in a week (0% probabilities). UUP(-14%) VXX(-12%) EDOC(-11%) TBT(-8%) IGOV(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $22.22(-30.08%) | Resistance Level | $34.81 | 5 Day Moving Average | $32.27(-1.52%) | 10 Day Moving Average | $33.11(-4.02%) | 20 Day Moving Average | $34.81(-8.7%) | To recent high | -39.6% | To recent low | 0% | Market Cap | $4.343b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |